1. Muscle weakness and mitochondrial stress occur before severe metastasis in a novel mouse model of ovarian cancer cachexia
   Luca J. Delfinis et al, 2024, Molecular Metabolism CrossRef
2. Extracellular vesicles in tumor-adipose tissue crosstalk: key drivers and therapeutic targets in cancer cachexia
   Cátia C. Ramos et al, 2024, Extracellular Vesicles and Circulating Nucleic Acids CrossRef
3. Gene regulatory roles of growth and differentiation factors in retinal development
   Ziming Luo et al, 2024, iScience CrossRef
4. GDF-15 and mtDNA Deletions Are Useful Biomarkers of Mitochondrial Dysfunction in Insulin Resistance and PCOS
   Vera Varhegyi et al, 2024, International Journal of Molecular Sciences CrossRef
5. Tryptophan metabolism and kynurenine metabolites in cancer: systemic nutritional and metabolic implications
   Alessio Molfino et al, 2024, Current Opinion in Clinical Nutrition & Metabolic Care CrossRef
6. Growth differentiation factor 15 is not modified after weight loss induced by liraglutide in South Asians and Europids with type 2 diabetes mellitus
   Carlijn A. Hoekx et al, 2024, Experimental Physiology CrossRef
7. Cancer-triggered systemic disease and therapeutic targets
   Yihai Cao, 2024, Holistic Integrative Oncology CrossRef
8. Central neural mechanisms of cancer cachexia
   Michael S. Yule et al, 2024, Current Opinion in Supportive & Palliative Care CrossRef
9. Bitter-tasting drugs tune GDF15 and GLP-1 expression via bitter taste or motilin receptors in the intestine of patients with obesity
   Qian Wang et al, 2024, Molecular Metabolism CrossRef
10. GDF15 and LCN2 for early detection and prognosis of pancreatic cancer
    Xinxia Zhu et al, 2024, Translational Oncology CrossRef
11. Hypothesis paper: GDF15 demonstrated promising potential in Cancer diagnosis and correlated with cardiac biomarkers
    Xiaohe Hao et al, 2024, Cardio-Oncology CrossRef